Moderna Inc (MRNA)
60.20
-0.87
(-1.42%)
USD |
NASDAQ |
Oct 04, 16:00
60.28
+0.08
(+0.13%)
After-Hours: 20:00
Moderna Shareholders Equity (Annual): 13.85B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.85B |
| December 31, 2022 | 19.12B |
| December 31, 2021 | 14.14B |
| December 31, 2020 | 2.561B |
| Date | Value |
|---|---|
| December 31, 2019 | 1.175B |
| December 31, 2018 | 1.530B |
| December 31, 2017 | 625.30M |
| December 31, 2016 | 841.85M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
1.175B
Minimum
2019
19.12B
Maximum
2022
10.17B
Average
13.85B
Median
2023
Shareholders Equity (Annual) Benchmarks
| Eli Lilly and Co | 10.77B |
| Merck & Co Inc | 37.58B |
| Pfizer Inc | 89.01B |
| Novavax Inc | -716.93M |
| Amgen Inc | 6.232B |